IPP Bureau
Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr
By IPP Bureau - August 06, 2025
Cenexi reports an EBITDA breakeven for the quarter
AbbVie submits for FDA approval of Venclexta and Acalabrutinib combination for untreated CLL patients
By IPP Bureau - August 06, 2025
The submission is supported by positive results from the Phase 3 AMPLIFY trial
Athena Diagnostics enhances Ataxia testing with long-read gene sequencing
By IPP Bureau - August 06, 2025
Athena is also exploring the use of this technology for expanded carrier screening
AbbVie announces positive Phase 3 results for Upadacitinib in Alopecia Areata
By IPP Bureau - August 06, 2025
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Cadila Pharmaceuticals launches Vasograin Plus for treatment of migraines
By IPP Bureau - August 06, 2025
Vasograin Plus represents a major advancement in the treatment of migraine
Roche’s Susvimo maintains vision over five years
By IPP Bureau - August 06, 2025
Novo Nordisk files 14 new lawsuits against unapproved semaglutide drugs
By IPP Bureau - August 06, 2025
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
Vertex faces regulatory delays for Journavx and reports VX-993 Phase 2 trial failure
By IPP Bureau - August 06, 2025
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
Aster DM Healthcare to build Rs. 580 crore crore hospital in Bengaluru
By IPP Bureau - August 05, 2025
This will be Aster’s fifth hospital in Bengaluru
Sanofi Consumer Healthcare India reports Q2 2025 PAT at Rs. 60.7 Cr
By IPP Bureau - August 05, 2025
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
Eli Lilly inaugurates global capability centre in hyderabad to advance AI initiatives
By IPP Bureau - August 05, 2025
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
Strides Pharma Science report Q1 FY26 PAT at Rs. 105.6 Cr
By IPP Bureau - August 05, 2025
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
Hexaware Technologies appoints Shantanu Baruah as President & Global Head – Healthcare, Life Sciences, and Insurance
By IPP Bureau - August 04, 2025
Baruah will lead strategy, growth, and transformation across the HLS vertical, focusing on expanding digital health capabilities and accelerating AI adoption
Sanofi’s GPRC5D monoclonal antibody earns ODD in US for multiple myeloma
By IPP Bureau - August 03, 2025
Beta-HPV can directly cause skin cancer in immunocompromised people
By IPP Bureau - August 03, 2025
cSCC is one of the most common cancers in the U.S. and globally
